Related references
Note: Only part of the references are listed.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
Francois Quenet et al.
LANCET ONCOLOGY (2021)
Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response
Ruiping Wang et al.
GUT (2020)
HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?
Wim Ceelen
EJSO (2019)
Hyperthermic intraperitoneal chemotherapy: Rationale and technique
Santiago Gonzalez-Moreno et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
Long-Term Survivors of Metastatic Colorectal Cancer Treated with Systemic Chemotherapy Alone: A North Central Cancer Treatment Group Review of 3811 Patients, N0144
Grace K. Dy et al.
CLINICAL COLORECTAL CANCER (2009)
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer
Vic J. Verwaal et al.
ANNALS OF SURGICAL ONCOLOGY (2008)